Journal of Zhejiang University SCIENCE B · 2016 · 25 citations · 12 references
Life SciencesGeneticsMolecular GeneticsEpigeneticsEpigenomicsMedical GeneticsEpigenetic Regulation In NeurodegenerationNeurodegenerative Disease GeneticsNeurodegenerative DiseasesNeurodegenerative DisordersNeurogenetic DisordersSpinal Muscular AtrophyMethylation ProcessesPediatric Spinal Muscular Atrophy
The homozygous loss of the survival motor neuron 1 (SMN1) gene is the primary cause of spinal muscular atrophy (SMA), a neuromuscular degenerative disease. A genetically similar gene, SMN2, which is not functionally equivalent in all SMA patients, modifies the clinical SMA phenotypes. We analyzed the methylation levels of 4 CpG islands (CGIs) in SMN2 in 35 Chinese children with SMA by MassARRAY. We found that three CpG units located in CGI 1 (nucleotides (nt) -871, -735) and CGI 4 (nt +999) are significantly hypomethylated in SMA type III compared with type I or II children after receiving Bonferroni correction. In addition to the differentially methylated CpG unit of nt -871, the methylation level of the nt -290/-288/-285 unit was negatively correlated with the expression of SMN2 full-length transcripts (SMN2-fl). In addition, the methylation level at nt +938 was inversely proportional to the ratio of SMN2-fl and lacking exon 7 transcripts (SMN2-Δ7, fl/Δ7), and was not associated with the SMN2 transcript levels. Thus, we can conclude that SMN2 methylation may regulate the SMA disease phenotype by modulating its transcription.
12
Acute Exercise Remodels Promoter Methylation in Human Skeletal Muscle
Romain Barrès, Jie Yan, Brendan Egan et al. · Cell Metabolism · 2012 · 951 citations · Full text
Treatment of spinal muscular atrophy by sodium butyrate
Jan‐Gowth Chang, Hsiu-Mei Hsieh-Li, Yuh‐Jyh Jong et al. · Proceedings of the National Academy of Sciences · 2001 · 405 citations
Medicine, Neurology, Neuroscience +13